Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' ...

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

The key to these vaccines was messenger RNA (mRNA), DNA's less-famous cousin. The power of the mRNA platform is that vaccines ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...

This press release corrects and replaces the company’s press release issued today, 10/29, at 4:15 p.m. ET in order to correct a typographical ...

Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that ...

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent off-target effects and treatment-resistant tumor microenvironments have ...

The U.S. Department of Health and Human Services (HHS) terminated senior advisor Dr. Steven Hatfill after six months in his ...

A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...